Showing papers by "Ronald T. Burkman published in 1992"

TL;DR: The hormonal components of oral contraceptives exert major effects on plasma lipoprotein metabolism, primarily through the activity of progestin, and these effects are far less pronounced with lower dose preparations and with formulations using the newer progestins.